Alaunos Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-17.23-1.06-1.24
Price/Sales ratio
N/AN/AN/A
Earnings per Share (EPS)
$-0.13$-2.1$-1.8

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-16.13-8.67-4.22-10.43-5.05-4.45-6.70-3.03-3.74-0.48-3.30-5.05
Price/Sales ratio
373.43240.58101.6788.731.83KN/AN/A587.1748.233.39K42.63N/A
Price/Book Value ratio
15.1511.92-9.02-5.853.138.344.264.023.652.693.233.13
Price/Cash Flow ratio
-13.98-104.22K-11.96-10.37-5.42-19.40-9.26-3.80-4.82-0.56-4.26-5.42
Price/Free Cash Flow ratio
-13.91-2.46K-11.84-10.23-5.37-19.27-7.90-3.60-4.78-0.55-4.23-5.37
Price/Earnings Growth ratio
0.30-0.04-0.130.150.75-0.020.100.650.070.03-0.06-0.02
Dividend Yield
N/AN/A1.02%N/A6.33%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%N/AN/A-85.92%5.57%-95960%N/AN/A
Operating Profit Margin
-3168.17%-2772.39%-2409.37%-837.26%-36921.91%N/AN/A-19484.67%-1201.40%-685340%-1201.40%-36921.91%
Pretax Profit Margin
-2314.71%-2772.11%-2409.22%-850.25%-36381.50%N/AN/A-19786.68%-1291.23%-702800%-1291.23%-36381.50%
Net Profit Margin
-2314.71%-2772.11%-2409.22%-850.25%-36381.50%N/AN/A-19320.10%-1286.68%-702800%-1291.23%-36381.50%
Effective Tax Rate
73.75%0.01%-0.06%-3.91%1.78%-51.03%1.41%2.35%0.35%N/AN/A-51.03%
Return on Assets
-70.25%-78.11%-155.43%-51.43%-55.88%-163.05%-53.87%-81.05%-57.89%-425.26%-58.10%-58.10%
Return On Equity
-93.91%-137.44%213.84%56.11%-62.07%-187.26%-63.59%-132.44%-97.51%-557.15%-94.34%-94.34%
Return on Capital Employed
-126.41%-88.56%-182.58%-63.11%-62.99%2.34%-62.79%-98.38%-86.10%-543.31%-86.10%2.34%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.22N/A
Quick Ratio
4.078.416.634.358.888.427.104.911.644.221.618.42
Cash ratio
3.957.765.123.406.506.366.264.741.613.091.616.36
Days of Sales Outstanding
38.5437.571.111.084.66KN/AN/A1.01K0.49730.49N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/A1.84KN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A1.01K1.84K73N/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/A525.73310.63674.75183.7546.81N/A525.73
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A344.121.66K26.18N/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.000.000.260.26N/A0.400.40
Debt Equity Ratio
N/AN/AN/AN/AN/A0.000.000.420.44N/A0.680.68
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.21N/AN/A0.05N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.000.000.290.31N/A0.330.33
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-11.13N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-52.78-69.61-2.47-1.68N/A-1.49-1.49
Company Equity Multiplier
1.331.75-1.37-1.091.111.141.181.631.681.311.681.11
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-26.69-0.00-8.50-8.55-338.74N/AN/A-154.44-10.00-6.02K-10.00-338.74
Free Cash Flow / Operating Cash Flow Ratio
1.0042.21.001.011.001.001.171.051.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-52.78-69.61-2.47-1.68N/A-1.49-1.49
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-52.78-69.61-7.14-1.68N/A-1.68-1.68
Dividend Payout Ratio
N/AN/A-4.30%N/A-32.00%N/AN/AN/AN/AN/AN/A-32.00%